Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors is a research paper published in Acta Pharmaceutica Sinica B (2025). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Office of Research and Development
Grant: I01 BX004271
DOD
Grant: PC200522
National Cancer Institute
Grant: P30CA093373
Prostate Cancer Foundation
Grant: 16CHAL02
NIH
Grant: R01 CA259081
NIH
Grant: RO1 CA224900
NCI NIH HHS
Grant: R01 CA224900
National Institutes of Health
Grant: 3P30CA093373-07S2
Cancer Center Support Grant - P30
National Institutes of Health
Grant: 5R01CA259081-03
Targeting aberrant circadian regulator in advanced prostate cancer
National Institutes of Health
Grant: 5R01CA224900-05
Therapeutic targeting of orphan NR in ER-negative breast cancer
Comprehensive Cancer Center, University of California, Davis
US Department of Veterans Affairs
Fields of Study
Keywords